Prevalence of HIV Infection in Childbearing Women in the United States: Surveillance Using Newborn Blood Samples

JAMA: The Journal of the American Medical Association

Volumn 265, Issue 13, 1991, Pages 1704-1708

  Gwinn, Marta ^a   Pappaioanou, Marguerite ^a,e   George, J Richard ^a   Hannon, W Harry ^b   Wasser, Shari C ^a   Redus, Martha A ^a   Hoff, Rodney ^c,f   Grady, George F ^c   Willoughby, Anne ^d   Novello, Antonia C ^d,g   Petersen, Lyle R ^a   Dondero, Timothy J ^a   Curran, James W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c Massachusetts Department of Health   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SERODIAGNOSIS; UNITED STATES; VERTICAL TRANSMISSION;

ANONYMOUS TESTING; CENTERS FOR DISEASE CONTROL; CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; FEDERAL GOVERNMENT; FEMALES; HEALTH CARE AND PUBLIC HEALTH; PREGNANT WOMEN; SURVEY; UNITED STATES;

DATABASES, FACTUAL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HUMAN; IMMUNOGLOBULIN G; INCIDENCE; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; UNITED STATES;

EID: 0025825898     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03460130096029     Document Type: Article

References (30)

1. 1. HIV/AIDS Surveillance Report. Atlanta, Ga: Centers for Disease Control; October 1990:1-18.
2. 2. Hessol NA, Lifson AR, O’Malley PM, Doll LS, Jaffe HW, Rutherford GW. Prevalence, incidence and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol. 1989;130:1167-1175.
3. 3. Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature. 1989;338:251-253.
4. 4. Pappaioanou M, Dondero TJ Jr, Petersen LR, Onorato IM, Sanchez CD, Curran JW. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep. 1990;105:113-119.
5. 5. Pappaioanou M, George JR, Hannon WH, et al. HIV seroprevalence surveys of childbearing women—objectives, methods, and uses of the data. Public Health Rep. 1990;105:147-152.
6. 6. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women: estimation by testing samples of blood from newborns. N Engl J Med. 1988;318:525-530.
7. 7. Novick LF, Berns D, Stricof R, Stevens R, Pass K, Wethers J. HIV seroprevalence in newborns in New York State. JAMA. 1989;261:1745-1750.
8. 8. Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR. 1989;38(suppl No. S-7):1-7.
9. 9. National Center for Health Statistics. Births, marriages, divorces, and deaths for 1989. Monthly Vital Stat Rep. 1990;38(12):1-20.
10. 10. Oxtoby M. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1990;9:609-619.
11. 11. Projections of the population of the United States, by age, sex, and race: 1988 to 2080. Current Population Reports. Washington, DC: US Bureau of the Census; 1989. Series P-25, No. 1018.
12. 12. Selik RM, Hardy AM, Curran JW. Epidemiology of AIDS and HIV infection in women in the United States. In: Osborne N, ed. AIDS in Gynecology: Clinical Practice of Gynecology. New York, NY: Elsevier Science Publishing Co Inc; 1989;1:33-42.
13. 13. Selik RM, Castro KG, Pappaioanou M. Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health. 1988;78:1539-1545.
14. 14. Mitchell JL. Drug abuse and AIDS in women and their affected offspring. J Natl Med Assoc. 1989;81:841-842.
15. 15. Andiman WA. Virologic and serologic aspects of human immunodeficiency virus infection in infants and children. Semin Perinatol. 1989;13:16-26.
16. 16. Rogers MF, Ou C-Y, Rayfield M, et al. Use of the polumerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med. 1989;320:1649-1654.
17. 17. Gwinn M, George JR, Hannon WH, Hoff R, Pappaioanou M, Novello A. Estimates of HIV seroprevalence in childbearing women and incidence of infection in infants, United States. Presented at Sixth International Conference on AIDS; June 22, 1990; San Francisco, Calif. Abstract F.C.43.
18. 18. Mofenson LM, Hoff R, Grady GF. Trends in newborn HIV rates reveal the true proportion seen clinically. Presented at Fifth International AIDS Conference; June 5, 1989; Montreal, Quebec. Abstract M.A.P.14.
19. 19. Stricof RL, Novick LF, Glebatis D. HIV seroprevalence in newborns—New York State. Presented at Fifth Annual National Pediatric AIDS Conference; September 6, 1989; Los Angeles, Calif. Abstract.
20. 20. Hardy LM, ed. HIV Screening of Pregnant Women and Newborns. Washington, DC: National Academy Press; 1991. Committee on Prenatal and Newborn Screening for HIV Infection, Institute of Medicine.
21. 21. Human Immune Deficiency Virus Infections. Washington, DC: American College of Obstetricians and Gynecologists; 1988. ACOG technical bulletin, No. 123.
22. 22. Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR. 1987;36:509-515.
23. 23. Grant CM, Coye MJ. A statewide program of identification and early intervention of HIV positive women and children. Presented at Sixth International Conference on AIDS; June 21, 1990; San Francisco, Calif. Abstract Th.D.801.
24. 24. Centers for Disease Control. Guidelines for the prevention and control of congenital syphilis. MMWR. 1988;37(suppl S-1):1-13.
25. 25. Centers for Disease Control. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR. 1988;37:341-346,351.
26. 26. Weiblen B, Lee FK, Cooper ER, et al. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet. 1990;1:988-990.
27. 27. Lee FK, Nahmias AJ, Lowery S, et al. ELISPOT: a new approach to studying the dynamics of virus—immune system interaction for diagnosis and monitoring of HIV infection. AIDS Res Hum Retroviruses. 1989;5:517-523.
28. 28. Pizzo PA, Wilfert CM. Treatment considerations for children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1990;9:690-699.
29. 29. Hummel RF, Grant CM, Conviser R, Coye MJ. Statewide strategic planning: a treatment assessment program for the HIV epidemic. AIDS Public Pol. 1990;5:68-74.
30. 30. Arno PS, Shenson D, Siegel NF, Franks P, Lee PR. Economic and policy implications of early intervention in HIV disease. JAMA. 1989;262: 1493-1498.